STOCKHOLM, Sweden--(HSMN NewsFeed)--RaySearch Laboratories AB (STO:RAYB) and TomoTherapy Inc. announced today that the new software solution SharePlan(TM) has received 510(k) clearance by the FDA and can now be market launched.
SharePlan™ is an advanced treatment planning solution that enables transfer of treatment plans between TomoTherapy® Hi•Art® systems and conventional linear accelerators. The product uses highly sophisticated algorithms to automatically generate a selection of deliverable high-quality IMRT plans based on an existing Hi•Art® plan. This time-saving concept is an important tool for optimizing patient benefit and throughput at clinics that are introducing a Hi-Art® system into an environment with existing conventional linear accelerators.
Full text >>
Friday, January 30, 2009
First product from collaboration between RaySearch and TomoTherapy receives FDA clearance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment